Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Aclasta° |
4043 |
5mg |
100ml |
Solution for infusion |
927692 |
958354 |
3.31 |
D |
Omnipharma |
Chugai Pharma Manufacturing Co Ltd |
Actemra 200mg |
5901 |
200mg |
10ml |
Concentrate for solution for infusion |
1354433 |
1399200 |
3.31 |
D |
Omnipharma |
Chugai Pharma Manufacturing Co Ltd |
Actemra 400mg |
5902 |
400mg |
1x20ml |
Concentrate for solution for infusion |
2708867 |
2798399 |
3.31 |
D |
Omnipharma |
Chugai Pharma Manufacturing Co Ltd |
Actemra 80mg |
5900 |
80mg |
1x4ml |
Concentrate for solution for infusion |
541773 |
559680 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Afinitor 5mg |
5897 |
5mg |
Box of 30 |
Tablet |
9216331 |
9520952 |
3.31 |
D |
Mectapharm S.A.L. |
Mepha Ltd |
Aktiferrine F* |
1349 |
34mg/500µg/300µg |
Box of 30 |
Suscaps |
15509 |
16022 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Aminovit* |
1648 |
|
Box of 20 |
Tablet |
6618 |
6837 |
3.31 |
A |
Droguerie Phenicia |
Unichem Laboratories Ltd |
Amlocim 10mg* |
5592 |
10mg |
Box of 30 |
Tablet |
25189 |
25305 |
0.46 |
B |
Droguerie Phenicia |
Unichem Laboratories Ltd |
Amlocim 5mg* |
5591 |
5mg |
Box of 30 |
Tablet |
26283 |
27152 |
3.31 |
B |
Droguerie Phenicia |
Acino Pharma AG |
Amoximex* |
3760 |
1g |
Box of 10 |
Tablet |
12432 |
12843 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Ampilag* |
1649 |
500mg |
Box of 16 |
Capsule |
18692 |
19309 |
3.3 |
A |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Ancopir Ampoules° |
1273 |
10mg/200mg/50mg/1mg/2ml |
5x2ml |
Solution for injection |
9595 |
9912 |
3.3 |
A |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Ancopir SC Tablets* |
1274 |
200mg/100mg/300µg |
Box of 20 |
Tablet, Sugar-Coated |
10189 |
10526 |
3.31 |
A |
Omnipharma |
Cenexi SAS |
Anexate 0.5mg* |
1353 |
0.5mg |
5x5ml |
Solution for injection |
180026 |
185976 |
3.31 |
C |
Omnipharma |
F. Hoffmann La Roche Ltd |
Anexate 1mg* |
1354 |
1mg/10ml |
5x10ml |
Solution for injection |
605602 |
625618 |
3.31 |
D |
New Allpharma |
Medinova Ltd |
Anginova |
3847 |
0.25mg/1mg |
Box of 20 |
Lozenge |
5973 |
6170 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Antistin-Privin* |
2065 |
5mg/0.25mg/ml |
10ml |
Eye drops |
3789 |
3914 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Aredia 15mg* |
880 |
15mg |
4x10ml |
Powder for solution for injection |
517941 |
535060 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Aredia 30mg* |
881 |
30mg |
2x10ml |
Powder for solution for injection |
523840 |
541154 |
3.31 |
D |
Unknown |
F. Hoffmann La Roche Ltd |
Arovit* |
1358 |
50MIU |
Box of 30 |
Tablet, Sugar-Coated |
12568 |
12983 |
3.3 |
A |
Taba Chemipharm |
Tilotts Pharma AG |
Asacol Enema 4g* |
1010 |
4g |
100ml |
Rectal suspension |
20973 |
21666 |
3.3 |
A |
Taba Chemipharm |
Haupt Pharma Wulfing GmbH |
Asacol Suppositories |
1009 |
500mg |
Box of 20 |
Suppository |
43813 |
45262 |
3.31 |
B |
Taba Chemipharm |
Haupt Pharma Wulfing GmbH |
Asacol Tablets 400mg |
1008 |
400mg |
Box of 100 |
Tablet |
99875 |
103176 |
3.31 |
B |
Taba Chemipharm |
Haupt Pharma Wulfing GmbH |
Asacol Tablets 800mg |
5478 |
800mg |
Box of 60 |
Tablet |
118764 |
122689 |
3.3 |
C |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Atropine Novartis* |
2047 |
1% |
10ml |
Eye drops, solution |
6820 |
7045 |
3.3 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Aurorix* |
1361 |
150mg |
Box of 30 |
Tablet, Scored |
30961 |
31985 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Avastin 100mg |
5554 |
100mg |
1x4ml |
Concentrate for solution for infusion |
1210495 |
1250504 |
3.31 |
D |
Omnipharma |
Genentech Inc |
Avastin 100mg* |
3946 |
100mg |
1x4ml |
Concentrate for solution for infusion |
1210495 |
1250504 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Avastin 100mg² |
6109 |
100mg |
1x4ml |
Concentrate for solution for infusion |
1210495 |
1250504 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Avastin 400mg |
6110 |
400mg |
1x16ml |
Concentrate for solution for infusion |
4513991 |
4663186 |
3.31 |
D |
Omnipharma |
Genentech Inc |
Avastin 400mg* |
3945 |
400mg |
1x16ml |
Concentrate for solution for infusion |
4513991 |
4663186 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Avastin 400mg² |
5555 |
400mg |
1x16ml |
Concentrate for solution for infusion |
4513991 |
4663186 |
3.31 |
D |
PharmaLab SARL |
Labatec Pharma SA |
Axetocovit* |
1805 |
30000IU/80mg |
Box of 100 |
Tablet, Sugar-Coated |
21167 |
21867 |
3.31 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Bactrim Forte° |
1365 |
960mg |
Box of 10 |
Tablet |
11486 |
11866 |
3.31 |
A |
Omnipharma |
Cenexi SAS |
Bactrim Syrup |
1366 |
240mg/5ml |
100ml |
Syrup |
9000 |
9297 |
3.3 |
A |
Pharmacie Traboulsi |
Geistlich Pharma AG |
Batramycin* |
1799 |
300IU/5mg/g |
20g |
Cutaneous ointment |
8784 |
9074 |
3.3 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
F. Hoffmann La Roche Ltd |
Becozym Ampoules* |
1367 |
multicompo |
50x2ml |
Solution for injection |
81477 |
84170 |
3.31 |
B |
Droguerie R. Pharaon & Fils S.A.L. |
F. Hoffmann La Roche Ltd |
Becozym Syrup* |
1368 |
multicompo |
100ml |
Syrup |
7378 |
7622 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Bedranol 10mg |
1651 |
10mg |
Box of 60 |
Tablet, Film-Coated |
5633 |
5819 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Bedranol 40mg |
1652 |
40mg |
Box of 60 |
Tablet, Film-Coated |
10104 |
10437 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Bedranol 80mg* |
1653 |
80mg |
Box of 60 |
Tablet |
11619 |
12003 |
3.3 |
A |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Begrocit* |
1275 |
multicompo |
Box of 10 |
Tablet, Effervescent |
8108 |
8376 |
3.31 |
A |
Unknown |
F. Hoffmann La Roche Ltd |
Benadon* |
1370 |
300mg |
Box of 10 |
Tablet |
12297 |
12704 |
3.31 |
A |
Unknown |
F. Hoffmann La Roche Ltd |
Benerva* |
1371 |
300mg |
Box of 20 |
Tablet |
9459 |
9772 |
3.31 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
F. Hoffmann La Roche Ltd |
Berocca Calcium Magnesium* |
1375 |
multicompo |
Box of 30 |
Tablet, Film-Coated |
18919 |
19544 |
3.3 |
A |
Omnipharma |
Roche Diagnostics GmbH
|
Bondronat Injectable 1mg* |
2442 |
1mg/ml |
1x2ml |
Solution for infusion |
1337916 |
1382136 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Bondronat Injectable 2mg* |
2657 |
2mg/2ml |
1x2ml |
Solution for infusion |
2312447 |
2388877 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Bondronat Injectable 6mg° |
5265 |
6mg/6ml |
1x6ml |
Concentrate for solution for infusion |
748006 |
772729 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Bondronat Tablets* |
3966 |
50mg |
Box of 28 |
Tablet, Film-Coated |
722475 |
746354 |
3.31 |
D |
Omnipharma |
Vetter Pharma- Fertigung GmbH & Co KG |
Bonviva Injectable° |
5899 |
3mg/3ml |
1x3ml |
Solution for injection |
273270 |
282302 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Brinerdin* |
821 |
multicompo |
Box of 30 |
Tablet, Sugar-Coated |
10000 |
10331 |
3.31 |
A |
UPO S.A.L. |
OM Pharma |
Broncho-Vaxom Adults |
6467 |
multicompo |
Box of 30 |
Capsule, hard |
56771 |
58648 |
3.31 |
B |
UPO S.A.L. |
OM Pharma |
Broncho-Vaxom Adults* |
1270 |
multicompo |
Box of 10 |
Capsule, hard |
20055 |
20718 |
3.31 |
A |
UPO S.A.L. |
OM Pharma |
Broncho-Vaxom Children |
6466 |
multicompo |
Box of 30 |
Capsule, hard |
38423 |
39693 |
3.31 |
B |
UPO S.A.L. |
OM Pharma |
Broncho-Vaxom Children* |
1269 |
multicompo |
Box of 10 |
Capsule, hard |
13564 |
14012 |
3.3 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
Laboratorio Farmaceutico (SIT) Specialita Igienico Terapeutiche S.r.l. |
Buccaline* |
3428 |
multicompo |
Box of 7 |
Tablet |
5607 |
5793 |
3.32 |
A |
New Allpharma |
Medinova Ltd |
Butadilat* |
3845 |
|
30g |
Cutaneous Cream |
7432 |
7678 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
CA-C 1000 Sandoz* |
2004 |
1g/0.327g/1g/1g |
Box of 10 |
Tablet, Effervescent |
6054 |
6254 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Cafergot PB* |
823 |
100mg/2mg/60mg |
Box of 6 |
Suppository |
8784 |
9074 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharmaceuticals UK Ltd, Horsham |
Cafergot* |
822 |
100mg/1mg |
Box of 20 |
Tablet |
7568 |
7818 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
CAL DE CE Effervescent* |
871 |
|
Box of 10 |
Tablet, Effervescent |
7432 |
7678 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Calcibronat* |
824 |
2g |
Box of 10 |
Tablet, Effervescent |
6351 |
6561 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Calcium + Vitamin C Citron* |
828 |
|
Box of 10 |
Tablet, Effervescent |
6757 |
6980 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Calcium + Vitamin C Orange* |
827 |
|
Box of 10 |
Tablet, Effervescent |
6757 |
6980 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Calcium + Vitamin C* |
826 |
500mg |
5x10ml |
Oral solution, Ampoule |
12162 |
12564 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Calcium Forte* |
825 |
500mg |
Box of 10 |
Tablet, Effervescent |
12162 |
12564 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Calcium Sandoz Forte° |
1979 |
500mg |
Box of 20 |
Tablet, Effervescent |
12162 |
12564 |
3.31 |
A |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Cegrovit* |
1276 |
1g |
Box of 10 |
Tablet, Effervescent |
6108 |
6310 |
3.31 |
A |
Omnipharma |
Roche SpA Italy under licence from F. Hoffmann La Roche Ltd Switzerland |
Cellcept 250mg |
3906 |
250mg |
Box of 100 |
Capsule, hard |
246158 |
254294 |
3.31 |
D |
Omnipharma |
Roche SpA Italy under licence from F. Hoffmann La Roche Ltd Switzerland |
Cellcept 500mg |
3907 |
500mg |
Box of 50 |
Tablet |
246158 |
254294 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Cellcept 500mg* |
3403 |
500mg |
Box of 150 |
Tablet |
1198697 |
1238316 |
3.31 |
D |
Pharmamedic S.A.R.L. |
Mepha Ltd |
Cerepar* |
1399 |
75mg |
Box of 50 |
Tablet |
24046 |
24841 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Certican 0.5mg |
5116 |
0.5mg |
Box of 60 |
Tablet |
643242 |
664502 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Certican 0.75mg |
5117 |
0.75mg |
Box of 60 |
Tablet |
1074666 |
1110186 |
3.31 |
D |
Alisar Pharma Corp |
IBSA |
Choriomon* |
769 |
5000IU |
3+3 |
Powder and solvent for solution for injection |
28135 |
29065 |
3.31 |
B |
Mersaco |
Cilag AG |
Cilest* |
1910 |
0.035mg/0.25mg |
Box of 21 |
Tablet |
9865 |
10191 |
3.3 |
A |
Mersaco |
Cilag AG |
Ciloprine Cum Anaesthetico* |
1915 |
0.84g/0.96g/0.42g |
12g |
Ear drops, solution |
6703 |
6924 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Co-Diovan 160/12.5mg° |
816 |
160/12.5mg |
Box of 28 |
Tablet, Film-Coated |
39713 |
41026 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Co-Diovan 160/25mg° |
819 |
160/25mg |
Box of 28 |
Tablet, Film-Coated |
39713 |
41026 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Co-Diovan 320/12.5mg* |
5933 |
320/12.5mg |
Box of 28 |
Tablet, Film-Coated |
73617 |
76050 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma S.P.A. |
Co-Diovan 320/25mg* |
5932 |
320/25mg |
Box of 28 |
Tablet, Film-Coated |
89537 |
92497 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Co-Diovan 80/12.5mg° |
811 |
80/12.5mg |
Box of 28 |
Tablet, Film-Coated |
33484 |
34591 |
3.31 |
B |
Mectapharm S.A.L. |
Lek Pharmaceuticals dd |
CoAmox Lactabs 1g* |
6156 |
1g |
Box of 12 |
Lactabs |
17580 |
18161 |
3.3 |
A |
Mectapharm S.A.L. |
Lek Pharmaceuticals dd |
CoAmox Suspension 156.25mg* |
6155 |
156.25mg//5ml |
100ml |
Powder for oral suspension |
7729 |
7985 |
3.31 |
A |
Mectapharm S.A.L. |
Lek Pharmaceuticals dd |
CoAmox Suspension 312mg* |
6154 |
312.5mg/5ml |
100ml |
Powder for oral suspension |
10786 |
11142 |
3.3 |
A |
Mectapharm S.A.L. |
Lek Pharmaceuticals dd |
CoAmox Suspension 457mg* |
6153 |
457mg/5ml |
70ml |
Powder for oral suspension |
11114 |
11481 |
3.3 |
A |
Taba Chemipharm |
Tilotts Pharma AG |
Colpermin |
1025 |
187mg |
Box of 30 |
Prolonged-release capsule, hard |
10811 |
11168 |
3.3 |
A |
Taba Chemipharm |
Tilotts Pharma AG |
Colpermin* |
1026 |
187mg |
Box of 100 |
Prolonged-release capsule, hard |
24969 |
25794 |
3.3 |
B |
Mersaco |
Pharmaton SA |
Complex 23 Pharmaton* |
1874 |
|
Box of 30 |
Capsule |
18108 |
18707 |
3.31 |
A |
Alisar Pharma Corp |
IBSA |
Condrosulf* |
762 |
400mg |
Box of 60 |
Capsule, hard |
41101 |
42460 |
3.31 |
B |
Omnipharma |
Patheon Inc |
Copegus° |
3967 |
200mg |
Box of 168 |
Tablet, Film-Coated |
179853 |
185797 |
3.3 |
C |
Mectapharm S.A.L. |
Mepha Ltd |
Corotenol 100mg* |
1406 |
100mg |
Box of 14 |
Cardotabs |
39249 |
40546 |
3.3 |
B |
Mectapharm S.A.L. |
Mepha Ltd |
Corotenol 50mg* |
1407 |
50mg |
Box of 28 |
Cardotabs |
22783 |
23537 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Cortiphenol H* |
2051 |
10mg/10mg |
4g |
Eye ointment |
6567 |
6784 |
3.3 |
A |
Omnipharma |
JHP Pharmaceuticals LLC |
Cymevene Injectable°° |
6111 |
500mg |
10ml |
Solution for injection |
120273 |
122510 |
1.86 |
C |
Pharmacie Traboulsi |
Geistlich Pharma AG |
Decalcit Powder |
1801 |
600mg/750IU |
100g |
Oral powder |
18378 |
18986 |
3.31 |
A |
Pharmacie Traboulsi |
Geistlich Pharma AG |
Decalcit Tablets |
1800 |
600mg/500IU |
Box of 100 |
Tablet |
26283 |
27152 |
3.31 |
B |
Mectapharm S.A.L. |
Mepha Ltd |
Decatylen° |
1409 |
0.25mg/0.03mg |
Box of 20 |
Lozenge |
5052 |
5219 |
3.31 |
A |
New Allpharma |
Medinova Ltd |
Dexalocal Cream* |
3846 |
1mg/g |
20g |
Cutaneous Cream |
9459 |
9772 |
3.31 |
A |
New Allpharma |
Medinova Ltd |
Dexalocal Solution* |
3440 |
1mg/g |
30ml |
Cutaneous solution |
11162 |
11531 |
3.31 |
A |
New Allpharma |
Medinova Ltd |
Dexalocal-F* |
3441 |
1mg/5mg/g |
20g |
Cutaneous Cream |
10649 |
11001 |
3.31 |
A |
New Allpharma |
Medinova Ltd |
Dexalocal-J* |
3844 |
1mg/g/1% |
20g |
Cutaneous Cream |
11081 |
11447 |
3.3 |
A |
New Allpharma |
Medinova Ltd |
Dexasalyl Ointment* |
3442 |
3%/0.12%. |
20g |
Cutaneous ointment |
11243 |
11615 |
3.31 |
A |
New Allpharma |
Medinova Ltd |
Dexasalyl Solution* |
3443 |
3%/0.12%. |
30ml |
Cutaneous solution |
10297 |
10638 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Dialag* |
1663 |
5mg |
Box of 25 |
Tablet |
5683 |
5871 |
3.31 |
A |
Pharmaceutica S.A.R.L. |
OM Pharma |
Dicynone Ampoules |
1263 |
250mg |
4x2ml |
Solution for injection |
8891 |
9185 |
3.31 |
A |
Pharmaceutica S.A.R.L. |
OM Pharma |
Dicynone Ampoules* |
1264 |
250mg |
100x2ml |
Solution for injection |
188684 |
194921 |
3.31 |
C |
Pharmaceutica S.A.R.L. |
OM Pharma |
Dicynone Tablets 250mg* |
1265 |
250mg |
Box of 20 |
Tablet |
19879 |
20536 |
3.3 |
A |
Pharmaceutica S.A.R.L. |
OM Pharma |
Dicynone Tablets 500mg |
3603 |
500mg |
Box of 20 |
Tablet |
30038 |
31030 |
3.3 |
B |
Mectapharm S.A.L. |
Mepha Ltd |
Diltan 60mg SR* |
1412 |
60mg |
Box of 50 |
Cardocaps |
20864 |
21553 |
3.3 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Diltan 90mg SR* |
1413 |
90mg |
Box of 20 |
Cardocaps |
13185 |
13621 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Diovan 160mg²° |
815 |
160mg |
Box of 28 |
Tablet, Film-Coated |
44076 |
45533 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Diovan 320mg* |
5850 |
320mg |
Box of 28 |
Tablet, Film-Coated |
86208 |
89057 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Diovan 80mg* |
887 |
80mg |
Box of 28 |
Capsule, hard |
64551 |
66684 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Diovan 80mg° |
810 |
80mg |
Box of 28 |
Tablet, Film-Coated |
36638 |
37849 |
3.31 |
B |
Omnipharma |
Valeant Pharmaceuticals Switzerland GmbH |
Disflatyl Oral Drops* |
1282 |
40mg/ml |
30ml |
Oral drops, solution |
8297 |
8572 |
3.31 |
A |
Omnipharma |
Valeant Pharmaceuticals Switzerland GmbH |
Disflatyl Tablets° |
1281 |
40mg |
Box of 30 |
Tablet, Chewable |
5595 |
5780 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Diuresal |
1664 |
40mg |
Box of 24 |
Tablet |
6921 |
7150 |
3.31 |
A |
Omnipharma |
Cenexi SAS |
Dormicum Ampoules 1mg/ml* |
1422 |
5mg/5ml |
10x5ml |
Injectable/rectal Solution |
25705 |
26554 |
3.3 |
B |
Omnipharma |
Cenexi SAS |
Dormicum Ampoules 5mg/ml* |
1421 |
5mg/ml |
10x1ml |
Injectable/rectal Solution |
25705 |
26554 |
3.3 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Dormicum Tablets 15mg* |
1424 |
15mg |
Box of 30 |
Tablet |
20270 |
20940 |
3.31 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Dormicum Tablets 15mg** |
1423 |
15mg |
Box of 10 |
Tablet |
8108 |
8376 |
3.31 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Dormicum Tablets 7.5mg° |
1420 |
7.5mg |
Box of 10 |
Tablet |
5405 |
5584 |
3.31 |
A |
Pharmaceutica S.A.R.L. |
OM Pharma |
Doxium 500° |
1268 |
500mg |
Box of 60 |
Capsule |
94743 |
97875 |
3.31 |
B |
Pharmaceutica S.A.R.L. |
OM Pharma |
Doxium 500° |
1267 |
500mg |
Box of 30 |
Capsule |
49337 |
50967 |
3.3 |
B |
Multimarketing S.A.R.L. |
Lagap SA |
Doxylag |
1665 |
100mg |
Box of 10 |
Capsule, hard |
11114 |
11481 |
3.3 |
A |
Macromed S.A.R.L. |
Geymonat |
Ecomi Ovules* |
2494 |
150mg |
Box of 6 |
Pessary |
8566 |
19588 |
128.67 |
A |
Khalil Fattal & Fils S.A.L. |
Excelvision AG |
Efemoline* |
2066 |
1mg/0.25mg/ml |
5ml |
Eye drops |
4041 |
4175 |
3.32 |
A |
Omnipharma |
Novartis Pharma GmbH |
Elidel° |
543 |
1% |
15g |
Cutaneous Cream |
50663 |
52338 |
3.31 |
B |
Multimarketing S.A.R.L. |
Lagap SA |
Enterosuiss Capsules* |
1666 |
250mg |
Box of 12 |
Capsule |
9472 |
9785 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Enterosuiss Suspension* |
1667 |
125mg/5ml |
60ml |
Oral suspension |
8714 |
9002 |
3.31 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
Institut Serotherapique & Vaccinal Suisse Berne |
Epaxal Berna* |
3762 |
24IU |
10x0.5ml |
Solution for injection |
572728 |
591658 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Ephynal* |
1432 |
150IU |
Box of 20 |
Tablet, Sugar-Coated |
10054 |
10386 |
3.3 |
A |
Mersaco |
Cilag AG |
Eprex 10000IU* |
1939 |
10000IU |
6x1ml |
Solution for injection |
767455 |
792821 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 10000IU* |
1942 |
10000IU |
6x1ml |
Solution for injection |
767455 |
792821 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 2000IU* |
1940 |
2000IU |
6x0.5ml |
Solution for injection |
190326 |
196617 |
3.31 |
C |
Mersaco |
Cilag AG |
Eprex 2000IU* |
1937 |
2000IU |
6x1ml |
Solution for injection |
190326 |
196617 |
3.31 |
C |
Mersaco |
Cilag AG |
Eprex 40000IU* |
3642 |
40000IU |
1x1ml |
Solution for injection |
542487 |
560418 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 40000IU* |
1918 |
40000IU |
1x1ml |
Solution for injection |
542487 |
560418 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 4000IU* |
1938 |
4000IU |
6x1ml |
Solution for injection |
366546 |
378661 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 4000IU* |
1941 |
4000IU |
6x0.4ml |
Solution for injection |
366546 |
378661 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 5000IU* |
1916 |
5000IU |
6x0.5ml |
Solution for injection |
452226 |
467173 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 6000IU* |
1911 |
6000IU |
6x0.6ml |
Solution for injection |
542487 |
560418 |
3.31 |
D |
Mersaco |
Cilag AG |
Eprex 8000IU* |
1917 |
8000IU |
6x0.8ml |
Solution for injection |
723561 |
747476 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Estracomb TTS* |
888 |
0.05mg/0.25mg |
4x4 |
Transdermal system |
37690 |
38935 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Estraderm TTS 25µg* |
882 |
25µg |
Box of 6 |
Transdermal system |
13892 |
14351 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Estraderm TTS 50µg* |
883 |
50µg |
Box of 6 |
Transdermal system |
20081 |
20745 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Eurax Cream* |
1975 |
10% |
20g |
Cutaneous Cream |
3789 |
3914 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Eurax Lotion* |
1977 |
10% |
50ml |
Cutaneous Lotion |
6365 |
6576 |
3.32 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Exelon Capsules 1.5mg* |
3511 |
1.5mg |
Box of 28 |
Capsule, hard |
112779 |
116508 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
LTS Lohmann Therapie System |
Exelon Patchs 10 |
5711 |
9.5mg/24h |
Box of 30 |
Transdermal system |
277200 |
286362 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
LTS Lohmann Therapie System |
Exelon Patchs 5 |
5710 |
4.6mg/24h |
Box of 30 |
Transdermal system |
277200 |
286362 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Exforge 10/160mg° |
5052 |
10/160mg |
Box of 28 |
Tablet, Film-Coated |
76719 |
79256 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Exforge 5/160mg° |
5051 |
5/160mg |
Box of 28 |
Tablet, Film-Coated |
69334 |
71626 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Exforge HCT 10/160/12.5mg° |
5921 |
10/160/12.5mg |
Box of 14 |
Tablet, Film-Coated |
79925 |
82567 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Exforge HCT 10/160/25mg° |
5922 |
10mg/160mg/25mg |
Box of 14 |
Tablet, Film-Coated |
79925 |
82567 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Exforge HCT 5/160/12.5mg° |
5923 |
5/160/12.5mg |
Box of 14 |
Tablet, Film-Coated |
78498 |
81093 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Exforge HCT 5/160/25mg° |
5920 |
5mg/160mg/25mg |
Box of 14 |
Tablet, Film-Coated |
79499 |
82127 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Exjade 125mg* |
3925 |
125mg |
Box of 28 |
Tablet, Dispersible |
349799 |
361361 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Exjade 250mg* |
3926 |
250mg |
Box of 28 |
Tablet, Dispersible |
695016 |
717988 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Exjade 500mg* |
3927 |
500mg |
Box of 28 |
Tablet, Dispersible |
1380823 |
1426463 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Bayer Shering Pharma AG for Novartis Pharma AG Switzerland |
Extavia* |
6560 |
300µg |
15+15x1.2ml |
Powder and solvent for solution for injection |
2133639 |
2204161 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Femara |
890 |
2.5mg |
Box of 30 |
Tablet, Film-Coated |
409681 |
423221 |
3.31 |
D |
Mersaco |
Famar Italia SpA |
Fenistil 24* |
1986 |
4mg |
Box of 10 |
Prolonged-release capsule, hard |
6466 |
6680 |
3.31 |
A |
Mersaco |
Novartis Farmaceutica SA |
Fenistil Coated Tablets* |
1982 |
1mg |
Box of 20 |
Tablet, Sugar-Coated |
4016 |
4149 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Fenistil Drops° |
1983 |
1mg/ml |
20ml |
Oral drops, solution |
5582 |
5767 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Fenistil Gel* |
1985 |
1mg/g |
30g |
Cutaneous Gel |
4698 |
4853 |
3.3 |
A |
Mersaco |
ZYMA SA |
Fenistil Retard* |
3643 |
1mg |
Box of 20 |
Tablet, Prolonged-release |
10609 |
10959 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Fenistil Syrup* |
1984 |
1mg/10ml |
100ml |
Syrup |
7830 |
8089 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Flamon Lactab 80* |
1437 |
80mg |
Box of 20 |
Lactabs |
8386 |
8663 |
3.3 |
A |
Alisar Pharma Corp |
IBSA |
Flector E.P. Gel* |
766 |
1% |
60g |
Cutaneous Gel |
7679 |
7932 |
3.29 |
A |
Alisar Pharma Corp |
IBSA |
Flector E.P. Granulates |
767 |
50mg |
Box of 10 |
Granules for oral solution |
11619 |
12003 |
3.3 |
A |
Alisar Pharma Corp |
IBSA |
Flector E.P. Tissugel |
765 |
1% |
Box of 5 plasters |
Tissugel |
22101 |
22832 |
3.31 |
A |
Alisar Pharma Corp |
IBSA |
Flector Tablets 100mg* |
764 |
100mg |
Box of 10 |
Tablet, Prolonged-release |
9194 |
9498 |
3.31 |
A |
Alisar Pharma Corp |
IBSA |
Flector Tablets 50mg* |
763 |
50mg |
Box of 20 |
Tablet, Gastro-resistant |
10205 |
10542 |
3.3 |
A |
Biofine Pharma Middle East S.A.L. |
Zambon Switzerland Ltd |
Fluimucil Effervescent |
5912 |
600mg |
Box of 10 |
Tablet, Effervescent |
10000 |
10331 |
3.31 |
A |
Droguerie Phenicia |
Siegfried CMS AG Ltd |
Fluocim* |
3759 |
20mg |
Box of 14 |
Capsule |
27334 |
28238 |
3.31 |
B |
New Allpharma |
Rottendorf Pharma GmbH |
Fluomizin |
6182 |
10mg |
Box of 6 |
Tablet, Vaginal |
11366 |
11742 |
3.31 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Fluoro-Uracil* |
1438 |
250mg |
5x5ml |
Solution for injection |
40607 |
41949 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Foradil |
889 |
12µg |
Box of 60 |
Inhalation powder, hard capsule |
72567 |
74966 |
3.31 |
B |
Alisar Pharma Corp |
IBSA |
Fostimon 150IU |
3905 |
150IU |
10+10x1ml |
Powder and solvent for solution for injection |
601708 |
621595 |
3.31 |
D |
Alisar Pharma Corp |
IBSA |
Fostimon 75IU |
3904 |
75IU |
10+10x1ml |
Powder and solvent for solution for injection |
304691 |
314762 |
3.31 |
D |
Alisar Pharma Corp |
IBSA |
Fostimon 75IU* |
768 |
75IU |
10x1ml |
Solution for injection |
248289 |
256495 |
3.31 |
D |
Droguerie Phenicia |
Unichem Laboratories Ltd |
Fuzocim* |
5703 |
10mg |
Box of 30 |
Tablet, Prolonged-release |
36428 |
37632 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Galvusmet 50/1000mg° |
5578 |
50mg/1g |
Box of 60 |
Tablet, Film-Coated |
74693 |
77162 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Galvusmet 50/850mg° |
5601 |
50mg/850mg |
Box of 60 |
Tablet, Film-Coated |
71890 |
74266 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Galvus° |
5505 |
50mg |
Box of 28 |
Tablet |
61327 |
63354 |
3.31 |
B |
Mectapharm S.A.L. |
Sofarimex Ltd |
Gasec 20mg° |
4074 |
20mg |
Box of 14 |
Capsule, hard |
22733 |
23484 |
3.3 |
A |
Mectapharm S.A.L. |
Sofarimex Ltd |
Gasec 40mg° |
5514 |
40mg |
Box of 14 |
Gastro-resistant capsule, hard |
40551 |
41891 |
3.3 |
B |
Mersaco |
Ginsana SA |
Geriatric Pharmaton* |
1875 |
multicompo |
Box of 30 |
Capsule, soft |
26283 |
27152 |
3.31 |
B |
Mersaco |
Ginsana SA |
Geriatric Pharmaton* |
1876 |
multicompo |
Box of 100 |
Capsule, soft |
68703 |
70974 |
3.31 |
B |
Pharmacie Traboulsi |
Geistlich Pharma AG |
Gewodin* |
1802 |
30mg/250mg/150mg |
Box of 10 |
Tablet |
3243 |
3350 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Gilenya |
6306 |
0.5mg |
Box of 28 |
Capsule |
5198075 |
5369883 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Glivec Capsules 100mg* |
813 |
100mg |
Box of 120 |
Capsule, hard |
5906814 |
6102048 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Glivec Tablets 100mg |
4041 |
100mg |
Box of 60 |
Tablet, Film-Coated |
3108857 |
3211612 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Glivec Tablets 400mg* |
4042 |
400mg |
Box of 30 |
Tablet, Film-Coated |
6217713 |
6423223 |
3.31 |
D |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Grofenac Ampoules° |
1279 |
75mg |
5x3ml |
Solution for injection |
10540 |
10889 |
3.31 |
A |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Grofenac Retard |
1277 |
100mg |
Box of 10 |
Tablet, Prolonged-release |
8703 |
8990 |
3.3 |
A |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Grofenac Tablets 50mg |
1278 |
50mg |
Box of 20 |
Tablet, Coated |
9459 |
9772 |
3.31 |
A |
Mersaco |
Xian- Janssen Pharmaceutical Ltd |
Gyno-Pevaryl Depot* |
5895 |
150mg |
Box of 2 |
Prolonged-release pessary |
13622 |
14072 |
3.3 |
A |
Mersaco |
Cilag AG |
Gyno-Pevaryl Depot** |
1925 |
150mg |
Box of 2 |
Prolonged-release pessary |
13622 |
14072 |
3.3 |
A |
Mersaco |
Cilag AG |
Gyno-Pevaryl Ovules 150mg * |
1924 |
150mg |
Box of 3 |
Pessary |
12973 |
13402 |
3.31 |
A |
Mersaco |
Xian- Janssen Pharmaceutical Ltd |
Gyno-Pevaryl Ovules 150mg ** |
5919 |
150mg |
Box of 3 |
Pessary |
11297 |
11671 |
3.31 |
A |
Mersaco |
Cilag AG |
Gyno-Pevaryl Ovules 50mg* |
1923 |
50mg |
Box of 15 |
Pessary |
26861 |
27749 |
3.31 |
B |
Mersaco |
Cilag AG |
Gyno-Pevaryl Vaginal Cream** |
1922 |
1% |
78g |
Vaginal cream |
18567 |
19181 |
3.31 |
A |
Mersaco |
Robapharm
|
Gyno-Tardyferon |
1870 |
80mg/0.35mg |
Box of 30 |
Tablet, slow release |
16865 |
17422 |
3.3 |
A |
Mersaco |
Robapharm
|
Gyno-Tardyferon* |
1871 |
80mg/0.35mg |
Box of 100 |
Tablet, slow release |
49701 |
51344 |
3.31 |
B |
New Allpharma |
Medinova Ltd |
Gynoflor |
1007 |
0.03mg/10MIU |
Box of 6 |
Tablet, Vaginal |
14595 |
15077 |
3.3 |
A |
Omnipharma |
Roche Diagnostics GmbH
|
Herceptin 150mg²* |
5563 |
150mg |
1x15ml |
Powder for concentrate for solution for infusion |
2188944 |
2261292 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Herceptin 150mg¹* |
1461 |
150mg |
1x15ml |
Powder for concentrate for solution for infusion |
2222781 |
2296247 |
3.31 |
D |
Omnipharma |
Genentech Inc |
Herceptin 440mg° |
3873 |
440mg |
Box of 1 |
Powder for concentrate for solution for infusion |
6519685 |
6735172 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Herpidu* |
2080 |
1mg |
10ml |
Eye drops |
10811 |
11168 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Mipharm SpA |
Hydergine Drops* |
830 |
1mg/ml |
15ml |
Oral drops, solution |
3513 |
3630 |
3.33 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Hydergine Tablets* |
829 |
1.5mg |
Box of 30 |
Tablet |
13784 |
14239 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Hypolag* |
1674 |
250mg |
Box of 30 |
Tablet, Film-Coated |
10786 |
11142 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Excelvision AG |
HypoTears Gel* |
2049 |
10mg/g |
10ml |
Eye Gel |
7325 |
7567 |
3.3 |
A |
Alisar Pharma Corp |
IBSA |
Ialugen Plus Cream |
771 |
2mg/10mg/g |
60g |
Cutaneous Cream |
18186 |
18787 |
3.3 |
A |
Alisar Pharma Corp |
IBSA |
Ialugen Plus Gauze |
772 |
0.5mg/10mg/g |
Box of 10 |
Impregnated dressing |
25006 |
25600 |
2.38 |
B |
Mersaco |
Novartis Consumer Health SA |
Importal Sachet* |
1996 |
10g |
20x10g |
Powder for oral solution |
11291 |
11664 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Importal Solution* |
2000 |
667g/ml |
200ml |
Oral solution |
11392 |
11768 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Infectoflam Eye drops* |
2067 |
1mg/5mg/ml |
5ml |
Eye drops, suspension |
4723 |
4880 |
3.32 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Infectoflam Eye Ointment* |
2052 |
1mg/3mg/g |
4g |
Eye ointment |
8083 |
8350 |
3.3 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
Institut Serotherapique & Vaccinal Suisse Berne |
Inflexal V* |
3431 |
15µg |
1
x0.5ml |
Solution for injection |
20207 |
20875 |
3.31 |
A |
Omnipharma |
Roche Farma SA |
Inhibace 2.5mg* |
1467 |
2.5mg |
Box of 28 |
Tablet, Scored |
33957 |
35080 |
3.31 |
B |
Omnipharma |
Roche Farma SA |
Inhibace 5mg* |
1468 |
5mg |
Box of 28 |
Tablet, Scored |
50936 |
52620 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Inhibace Plus* |
1469 |
5mg/12.5mg |
Box of 28 |
Tablet, Film-Coated |
91333 |
94352 |
3.31 |
B |
Multimarketing S.A.R.L. |
Lagap SA |
Ipocol* |
1675 |
3g |
Box of 30 |
N/A |
55569 |
57406 |
3.31 |
B |
Multimarketing S.A.R.L. |
Lagap SA |
Lagaflex* |
1676 |
300mg/250mg |
Box of 20 |
Tablet |
7451 |
7698 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Lagasedive* |
1677 |
|
Box of 24 |
Tablet |
5810 |
6002 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Lagaspasm* |
1678 |
20mg/15mg |
Box of 20 |
Tablet |
5178 |
5349 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Lagatrim Forte* |
1681 |
960mg |
Box of 10 |
Tablet |
11998 |
12395 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Lagatrim Suspension* |
1679 |
240mg/5ml |
100ml |
Oral suspension |
7249 |
7489 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Lagatrim Tablets* |
1680 |
440mg |
Box of 20 |
Tablet |
13135 |
13569 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Lamisil Cream* |
858 |
1% |
15g |
Cutaneous Cream |
11432 |
11810 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Lamisil Dermagel* |
6136 |
1% |
15g |
Cutaneous Gel |
13741 |
14195 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Lamisil Once* |
6139 |
1% |
4g |
Cutaneous solution |
18944 |
19570 |
3.3 |
A |
Mersaco |
Novartis Pharma AG |
Lamisil Spray* |
1973 |
1% |
30ml |
Cutaneous solution |
22304 |
23041 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Lamisil Tablets 125mg* |
3468 |
125mg |
Box of 14 |
Tablet, Scored |
59110 |
61064 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharmaceuticals UK Ltd, Horsham |
Lamisil Tablets 250mg |
856 |
250mg |
Box of 14 |
Tablet, Scored |
74643 |
77111 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Lamisil Tablets 250mg* |
857 |
250mg |
Box of 28 |
Tablet, Scored |
225322 |
232769 |
3.31 |
D |
Mersaco |
Novartis Pharma AG |
Lamisil Topical Solution* |
1974 |
1% |
30ml |
Cutaneous solution |
30038 |
31030 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Lentaron Depot° |
884 |
250mg |
1x2ml |
Powder for solution for injection |
330350 |
341268 |
3.3 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharmaceuticals UK Ltd, Horsham |
Leponex 100mg° |
864 |
100mg |
Box of 50 |
Tablet, Scored |
98166 |
101411 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharmaceuticals UK Ltd, Horsham |
Leponex 25mg° |
863 |
25mg |
Box of 50 |
Tablet, Scored |
29226 |
30193 |
3.31 |
B |
PharmaLab SARL |
Labatec Pharma SA |
Lermacine* |
1806 |
125mg/250mg/250µg |
Box of 30 |
Tablet, Sugar-Coated |
8942 |
9237 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Lescol 20mg* |
3469 |
20mg |
Box of 28 |
Capsule, hard |
40659 |
42004 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Lescol 40mg° |
3450 |
40mg |
Box of 28 |
Capsule, hard |
56245 |
58104 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Lescol XL° |
812 |
80mg |
Box of 28 |
Tablet |
76746 |
79283 |
3.31 |
B |
Unknown |
Schering Plough Products Llc, Las Piedras subsidiary of Schering-Plough Corporation/ USA |
Leucomax 150µg* |
865 |
150µg |
1+1x1ml |
Powder and solvent for solution for injection |
127019 |
131217 |
3.31 |
C |
Unknown |
Schering Plough Products Llc, Las Piedras subsidiary of Schering-Plough Corporation/ USA |
Leucomax 300µg* |
866 |
300µg |
1+1x1ml |
Powder and solvent for solution for injection |
232986 |
240686 |
3.3 |
D |
Omnipharma |
Roche SpA |
Lexotanil 1.5mg* |
1485 |
1.5mg |
Box of 30 |
Tablet, Scored |
6946 |
7176 |
3.31 |
A |
Omnipharma |
Roche SpA |
Lexotanil 3mg* |
1486 |
3mg |
Box of 30 |
Tablet, Scored |
9270 |
9577 |
3.31 |
A |
Omnipharma |
Roche SpA |
Lexotanil 6mg° |
1487 |
6mg |
Box of 30 |
Tablet, Scored |
14297 |
14770 |
3.31 |
A |
Omnipharma |
Labiana Pharmaceuticals SL |
Librax¹° |
5575 |
5mg/2.5mg |
Box of 30 |
Tablet, Sugar-Coated |
9189 |
9493 |
3.31 |
A |
Pharma Marketing & Services |
Haupt Pharma Wolfratshausen GmbH |
Litak Injectable |
6562 |
2mg/ml |
5x5ml |
Solution for injection |
4337018 |
4480364 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Lomir SRO° |
859 |
5mg |
Box of 30 |
Capsule, hard |
51935 |
53652 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Lomir SRO°° |
860 |
5mg |
Box of 100 |
Capsule, hard |
192991 |
199370 |
3.31 |
C |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Lomir* |
851 |
2.5mg |
Box of 28 |
Tablet |
16865 |
17422 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Lomir** |
852 |
2.5mg |
Box of 56 |
Tablet |
59925 |
61906 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Lucentis 2.3mg |
5209 |
2.3mg/0.23ml |
1x0.23ml |
Solution for injection |
3276001 |
3384281 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Madopar 125* |
1495 |
25mg/100mg |
Box of 30 |
Controlled Release Capsules |
22919 |
23676 |
3.3 |
A |
UPO S.A.L. |
Vifor International |
Maltofer Drops° |
1118 |
50mg/ml |
30ml |
Oral drops, solution |
11081 |
11447 |
3.3 |
A |
UPO S.A.L. |
Vifor International |
Maltofer Fol° |
1116 |
100mg/0.35mg |
Box of 30 |
Tablet, Chewable |
14595 |
15077 |
3.3 |
A |
UPO S.A.L. |
Vifor International |
Maltofer Syrup° |
1117 |
10mg/ml |
150ml |
Syrup |
10081 |
10414 |
3.3 |
A |
Multimarketing S.A.R.L. |
G Streuli & Co SA |
Mechovit* |
1683 |
multicompo |
Box of 30 |
Capsule, hard |
9459 |
9772 |
3.31 |
A |
New Allpharma |
Medinova Ltd |
Mediplex* |
3848 |
|
100ml |
Syrup |
8216 |
8488 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Melix* |
1684 |
5mg |
Box of 30 |
Tablet |
9725 |
10046 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Melleril SC Tablets 10mg * |
831 |
10mg |
Box of 30 |
Tablet, Sugar-Coated |
4270 |
4411 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Melleril SC Tablets 25mg* |
832 |
25mg |
Box of 50 |
Tablet, Sugar-Coated |
9865 |
10191 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Melleril Suspension* |
834 |
0.2% |
100ml |
Oral suspension |
6757 |
6980 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Melleril Tablets* |
833 |
100mg |
Box of 30 |
Tablet |
18649 |
19265 |
3.3 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Mephamezone* |
1500 |
4mg/ml |
3x1ml |
Solution for injection |
12503 |
12916 |
3.3 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Mephanol 100mg* |
1501 |
100mg |
Box of 50 |
Tablet |
15155 |
15656 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Mephanol 300mg* |
1502 |
300mg |
Box of 30 |
Tablet |
22733 |
23484 |
3.3 |
A |
Alisar Pharma Corp |
IBSA Institut Biochimique SA |
Merional 150IU* |
6228 |
150IU |
10+10x2ml |
Powder and solvent for solution for injection |
402649 |
415957 |
3.31 |
D |
Alisar Pharma Corp |
IBSA |
Merional 75IU* |
770 |
75IU/75IU |
10+10x2ml |
Powder and solvent for solution for injection |
172530 |
178233 |
3.31 |
C |
Alisar Pharma Corp |
IBSA Institut Biochimique SA |
Merional 75IU* |
6227 |
75IU/75IU |
10+10x2ml |
Powder and solvent for solution for injection |
213307 |
220358 |
3.31 |
C |
Mectapharm S.A.L. |
Labesfal Laboratorios Almiro SA |
Mesporin 1g IM° |
3876 |
1g |
1+1x3.5ml |
Powder and solvent for solution for injection |
27534 |
28445 |
3.31 |
B |
Mectapharm S.A.L. |
Labesfal Laboratorios Almiro SA |
Mesporin 1g IV° |
3875 |
1g |
1+1x10ml |
Powder and solvent for solution for injection |
27534 |
28445 |
3.31 |
B |
Mectapharm S.A.L. |
Labesfal Laboratorios Almiro SA |
Mesporin 2g° |
3877 |
2g |
Box of 1 |
Powder for solution for injection |
47559 |
49132 |
3.31 |
B |
Mectapharm S.A.L. |
Labesfal Laboratorios Almiro SA |
Mesporin 500mg IM° |
3878 |
500mg |
1+1x2ml |
Powder and solvent for solution for injection |
13892 |
14352 |
3.31 |
A |
Mectapharm S.A.L. |
Labesfal Laboratorios Almiro SA |
Mesporin 500mg IV° |
3879 |
500mg |
1+1x5ml |
Powder and solvent for solution for injection |
13892 |
14352 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Methergin Ampoules* |
836 |
0.2mg/ml |
100x1ml |
Solution for injection |
88888 |
91827 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Methergin Ampoules° |
835 |
0.2mg/ml |
5x1ml |
Solution for injection |
4865 |
5026 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Methergin Drops* |
838 |
0.25mg/ml |
10ml |
Oral drops, solution |
7027 |
7259 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Produktions GmbH, Wehr |
Methergin SC Tablets° |
837 |
0.125mg |
Box of 30 |
Tablet, Sugar-Coated |
6757 |
6980 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Methocel° |
2068 |
2% |
30ml |
Eye drops |
12478 |
12890 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Metrolag Suspension 250mg* |
1688 |
250mg/5ml |
60ml |
Oral suspension |
4142 |
4279 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Metrolag Tablets 250mg |
1685 |
250mg |
Box of 20 |
Tablet |
7249 |
7489 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Metrolag Tablets 500mg |
1686 |
500mg |
Box of 24 |
Tablet |
15761 |
16282 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Metrolag Vaginal Tablets* |
1687 |
500mg |
Box of 10 |
Tablet, Vaginal |
7249 |
7489 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Miacalcic Ampoules 100IU° |
848 |
100IU |
5x1ml |
Solution for injection |
76746 |
79283 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Miacalcic Ampoules 50IU° |
847 |
50IU |
5x1ml |
Solution for injection |
67021 |
69237 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma SAS, Huningue |
Miacalcic Nasal Spray 200IU° |
3623 |
200IU |
14 doses |
Nasal spray, solution |
115513 |
119331 |
3.31 |
B |
UPO S.A.L. |
Leo Pharmaceutical Products |
Minihep Leo* |
3689 |
5000IU |
Box of 50 |
Solution for injection |
19567 |
20214 |
3.31 |
A |
Omnipharma |
Roche Diagnostics GmbH
|
Mircera FSP 100µg° |
5558 |
100µg |
1x0.3ml |
Solution for injection |
636206 |
657234 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Mircera FSP 150µg* |
5557 |
150µg |
1x0.3ml |
Solution for injection |
845058 |
872988 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Mircera FSP 200µg* |
5556 |
200µg |
1x0.3ml |
Solution for injection |
1104217 |
1140713 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Mircera FSP 50µg° |
5560 |
50µg |
1x0.3ml |
Solution for injection |
324120 |
334833 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Mircera FSP 75µg° |
5559 |
75µg |
1x0.3ml |
Solution for injection |
481603 |
497520 |
3.31 |
D |
Biofine Pharma Middle East S.A.L. |
Zambon Switzerland Ltd |
Monurol |
5916 |
3g |
1x3g |
Granules for oral solution |
16081 |
16613 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Mosegor* |
872 |
0.25mg/5ml |
100ml |
Syrup |
12027 |
12425 |
3.31 |
A |
Mersaco |
Lusomedicamenta Sociedade Tecnica Farmaceutica SA |
Motilium Suppositories Adults* |
6280 |
60mg |
Box of 6 |
Suppository |
7072 |
7306 |
3.31 |
A |
Mersaco |
Cilag AG |
Motilium Suppositories Adults** |
4034 |
60mg |
Box of 6 |
Suppository |
12301 |
12708 |
3.31 |
A |
Mersaco |
Cilag AG |
Motilium Suppositories Babies** |
4032 |
10mg |
Box of 6 |
Suppository |
5557 |
5741 |
3.31 |
A |
Mersaco |
Cilag AG |
Motilium Suppositories Children* |
4033 |
30mg |
Box of 6 |
Suppository |
8588 |
8872 |
3.31 |
A |
Mersaco |
Lusomedicamenta Sociedade Tecnica Farmaceutica SA |
Motilium Suppositories Children° |
6279 |
30mg |
Box of 6 |
Suppository |
6466 |
6680 |
3.31 |
A |
Mersaco |
Grunenthal Pharma AG |
Myco-Synalar Cream* |
1961 |
0.25mg/0.1mg/g |
15g |
Cutaneous Cream |
8588 |
8872 |
3.31 |
A |
Mersaco |
Grunenthal Pharma AG |
Myco-Synalar Solution* |
1950 |
10mg/50mg/0.1mg/g |
10ml |
Cutaneous solution |
6769 |
6993 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Mydriaticum* |
2054 |
0.5% |
10ml |
Eye drops, solution |
6567 |
6784 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Myfortic 180mg* |
817 |
180mg |
Box of 120 |
Tablet, Gastro-resistant |
411639 |
425245 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Myfortic 360mg° |
818 |
360mg |
Box of 120 |
Tablet, Gastro-resistant |
823326 |
850538 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Naclof* |
2077 |
0.1% |
5ml |
Eye drops, solution |
18186 |
18787 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Navoban Ampoules* |
861 |
5mg/5ml |
1x5ml |
Solution for injection |
58348 |
60277 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farmaceutica SA |
Navoban Capsules* |
862 |
5mg |
Box of 5 |
Capsule, hard |
221989 |
229326 |
3.31 |
C |
Omnipharma |
F. Hoffmann La Roche Ltd |
Neulastim° |
5552 |
6mg |
1x0.6ml |
Solution for injection |
3780002 |
3904937 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Neupogen 30MU Syringe° |
3839 |
30MU |
1
x0.5ml |
Solution for injection |
1532657 |
1583314 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Neupogen 30MU Vials° |
1506 |
30MU |
5x1ml |
Solution for injection |
1397237 |
1443418 |
3.31 |
D |
Mectapharm S.A.L. |
Merckle GmbH |
Neurorubine Ampoules° |
5657 |
100mg/100mg/1mg |
5x3ml |
Solution for injection |
10331 |
10672 |
3.3 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Neurorubine Forte Ampoules* |
1507 |
200mg/50mg/1000µg/10mg |
5x1ml |
Solution for injection |
10861 |
11220 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Llc |
Neurorubine Forte Lactabs° |
1508 |
200mg/50mg/1mg |
Box of 20 |
Lactabs |
5835 |
6028 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Excelvision AG |
Nyolol Ophthalmic Gel* |
2048 |
0.1% |
1x5g |
Eye Gel |
13766 |
14221 |
3.31 |
A |
New Allpharma |
Medinova Ltd |
Nystalocal |
3444 |
11.5mg/1mg/100.000IU/g |
20g |
Cutaneous Cream |
14946 |
15440 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Okacin* |
2061 |
3mg |
5ml |
Eye drops |
8841 |
9133 |
3.3 |
A |
Mectapharm S.A.L. |
Merckle GmbH |
Olfen Ampoules° |
1520 |
75mg |
5x2ml |
Solution for injection |
13084 |
13517 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Llc |
Olfen Depocap 100 SR° |
1516 |
100mg |
Box of 20 |
Dapocaps |
11240 |
11612 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Llc |
Olfen Depotabs 75 SR° |
1521 |
75mg |
Box of 30 |
Dépotabs |
19222 |
19857 |
3.3 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Olfen Gel* |
1514 |
1% |
20g |
Cutaneous Gel |
3890 |
4018 |
3.29 |
A |
Mectapharm S.A.L. |
Merckle GmbH |
Olfen Gel° |
1522 |
1% |
50g |
Cutaneous Gel |
8108 |
8376 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Olfen Lactabs 25mg* |
1517 |
25mg |
Box of 30 |
Lactabs |
11114 |
11481 |
3.3 |
A |
Mectapharm S.A.L. |
Mepha Llc |
Olfen Lactabs 50mg° |
1518 |
50mg |
Box of 20 |
Lactabs |
13387 |
13830 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Olfen Rectocaps 100mg° |
1515 |
100mg |
Box of 5 |
Rectal capsule |
8285 |
8559 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Olfen Rectocaps 50mg* |
1519 |
50mg |
Box of 10 |
Rectal capsule |
9800 |
10124 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Onbrez Breezhaler 150µg |
5891 |
150µg |
Box of 30 |
Inhalation powder, hard capsule |
92315 |
95367 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Onbrez Breezhaler 300µg* |
6379 |
300µg |
Box of 30 |
Inhalation powder, hard capsule |
92315 |
95367 |
3.31 |
B |
Mersaco |
Robapharm
|
Ossopan 200* |
1873 |
200mg |
Box of 30 |
Tablet, Sugar-Coated |
6838 |
7064 |
3.31 |
A |
Mersaco |
Robapharm
|
Ossopan 800 |
1872 |
800mg |
Box of 40 |
Tablet, Film-Coated |
21757 |
22476 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Otrivin Cold Menthol* |
6135 |
1‰ |
10ml |
Nasal spray, solution |
9043 |
9342 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Otrivin Nasal Drops 0.5‰* |
1997 |
0.5‰ |
10ml |
Nasal drops, solution |
3738 |
3862 |
3.32 |
A |
Mersaco |
Novartis Consumer Health SA |
Otrivin Nasal Drops 1‰ Nasal Drops° |
1998 |
1‰ |
10ml |
Nasal drops, solution |
5431 |
5610 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Otrivin Nasal Spray 1‰° |
1999 |
1‰ |
10ml |
Nasal spray, solution |
5330 |
5506 |
3.3 |
A |
Mersaco |
Cilag AG |
Parafon* |
1927 |
250mg/300mg |
Box of 30 |
Capsule, hard |
11027 |
11391 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Parlodel* |
839 |
2.5mg |
Box of 30 |
Tablet, Scored |
21622 |
22336 |
3.3 |
A |
Mersaco |
Cilag AG |
Pevaryl Cream* |
1921 |
1% |
30g |
Cutaneous Cream |
10622 |
10973 |
3.3 |
A |
Mersaco |
Cilag AG |
Pevaryl Foaming solution* |
1919 |
1% |
3x10g |
Cutaneous foam |
22973 |
23732 |
3.3 |
A |
Mersaco |
Cilag AG |
Pevaryl Spray* |
1920 |
1% |
30ml |
Cutaneous suspension |
13622 |
14072 |
3.3 |
A |
Mersaco |
Cilag AG |
Pevisone* |
1929 |
1%/0.1% |
15g |
Cutaneous Cream |
7946 |
8209 |
3.31 |
A |
Mersaco |
Ginsana SA |
Pharmaton Kiddi |
1877 |
multicompo |
200ml |
Syrup |
14919 |
15412 |
3.3 |
A |
Levant Alie Houses S.A.L. |
Golaz |
Pil-Food* |
895 |
multicompo |
Box of 100 |
Capsule |
48060 |
49649 |
3.31 |
B |
Fakhoury Pharmacy |
Diaform Ltd |
Polljuven* |
3988 |
400mg |
Box of 28 |
Capsule |
24248 |
25050 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Prednitracin* |
2059 |
250IU/3.5mg/5mg |
4g |
Eye ointment |
4673 |
4827 |
3.3 |
A |
Benta Trading S.A.R.L. |
CSL Behring AG |
Privigen 10g/100ml |
6672 |
10g/100ml |
100ml |
Solution for infusion |
1301365 |
1344377 |
3.31 |
D |
Benta Trading S.A.R.L. |
CSL Behring AG |
Privigen 2.5g/25ml° |
6671 |
2.5g/25ml |
1x25ml |
Solution for infusion |
325324 |
336076 |
3.31 |
D |
Benta Trading S.A.R.L. |
CSL Behring AG |
Privigen 5g/50ml° |
6670 |
5g/50ml |
50ml |
Solution for infusion |
650671 |
672176 |
3.31 |
D |
Mersaco |
Novartis Consumer Health SA |
Procto-Glyvenol Cream |
1981 |
2%/5% |
30g |
Rectal cream |
8209 |
8480 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Procto-Glyvenol Suppositories* |
1976 |
40mg/400mg |
Box of 10 |
Suppository |
6820 |
7045 |
3.3 |
A |
Mersaco |
Grunenthal Pharma AG |
Procto-Synalar N Ointment* |
1947 |
0.1mg/20mg |
15g |
Rectal ointment |
5203 |
5375 |
3.31 |
A |
Mersaco |
Grunenthal Pharma AG |
Procto-Synalar N Suppositories* |
1963 |
0.1mg/40mg |
Box of 10 |
Suppository |
7653 |
7906 |
3.31 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Prostigmin* |
3617 |
12.5mg/5ml |
1x5ml |
Solution for injection |
12270 |
12676 |
3.31 |
A |
Mersaco |
Grunenthal Pharma AG |
Proxen Suppositories* |
1951 |
500mg |
Box of 6 |
Suppository |
13513 |
13960 |
3.31 |
A |
Omnipharma |
Genentech Inc |
Pulmozyme |
6048 |
2.5mg |
30x2.5ml |
Inhalation solution |
2760236 |
2851466 |
3.31 |
D |
Omnipharma |
Roche Diagnostics GmbH
|
Rapilysin* |
2770 |
10IU |
2+2x10ml |
Powder and solvent for solution for injection |
3189832 |
3295261 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Rasilez 150mg° |
5299 |
150mg |
Box of 28 |
Tablet, Film-Coated |
86208 |
89057 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Rasilez 300mg° |
5300 |
300mg |
Box of 28 |
Tablet, Film-Coated |
103630 |
107055 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma S.P.A. |
Rasilez HCT 150mg/12.5mg° |
5649 |
150mg/12.5mg |
Box of 28 |
Tablet, Film-Coated |
93367 |
96453 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma S.P.A. |
Rasilez HCT 150mg/25mg° |
5652 |
150mg/25mg |
Box of 28 |
Tablet, Film-Coated |
93367 |
96453 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma S.P.A. |
Rasilez HCT 300mg/12.5mg° |
5650 |
300mg/12.5mg |
Box of 28 |
Tablet, Film-Coated |
111389 |
115071 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Farma S.P.A. |
Rasilez HCT 300mg/25mg° |
5651 |
300mg/25mg |
Box of 28 |
Tablet, Film-Coated |
111389 |
115071 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Rescula° |
2071 |
0.15% |
5ml |
Eye drops, solution |
50063 |
51717 |
3.3 |
B |
Mersaco |
Draxis Speciality Pharmaceuticals Inc |
Retin-A Cream* |
1934 |
0.05% |
30g |
Cutaneous Cream |
16730 |
17283 |
3.31 |
A |
Mersaco |
Draxis Speciality Pharmaceuticals Inc |
Retin-A Gel* |
1936 |
0.025mg |
30g |
Cutaneous Gel |
15378 |
15887 |
3.31 |
A |
Mersaco |
Cilag AG |
Retin-A Solution* |
1935 |
0.1% |
15ml |
Cutaneous solution |
17432 |
18009 |
3.31 |
A |
Pharmaceutica S.A.R.L. |
Osmopharm |
Rhinocap* |
4086 |
25mg/10mg/20mg |
Box of 10 |
Controlled Release Capsules |
9472 |
9785 |
3.3 |
A |
Benta Trading S.A.R.L. |
CSL Behring AG |
Rhophylac 300 |
4029 |
300µg |
1x2ml |
Solution for injection |
245096 |
253197 |
3.31 |
D |
Mersaco |
Cilag AG |
Risperdal Consta 25mg* |
1912 |
25mg |
1+1x2ml |
Powder and solvent for suspension for injection |
275894 |
285013 |
3.31 |
D |
Mersaco |
Cilag AG |
Risperdal Consta 37.5mg* |
1913 |
37.5mg |
1+1x2ml |
Powder and solvent for suspension for injection |
364003 |
376034 |
3.31 |
D |
Mersaco |
Cilag AG |
Risperdal Consta 50mg* |
1914 |
50mg |
1+1x2ml |
Powder and solvent for suspension for injection |
448056 |
462865 |
3.31 |
D |
Droguerie Fattal S.A.L. |
Novartis Farmaceutica SA |
Ritalin |
885 |
10mg |
Box of 30 |
Tablet |
6432 |
6645 |
3.31 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rivotril Oral Drops* |
1558 |
2.5mg/ml |
10ml |
Oral drops, solution |
8135 |
8404 |
3.31 |
A |
Omnipharma |
Roche Farma SA |
Rivotril Tablets 0.5mg° |
1559 |
0.5mg |
Box of 50 |
Tablet, Scored |
7784 |
8041 |
3.3 |
A |
Omnipharma |
Roche Farma SA |
Rivotril Tablets 2mg* |
1560 |
2mg |
Box of 100 |
Tablet, Scored |
26887 |
27776 |
3.31 |
B |
Omnipharma |
Roche Farma SA |
Rivotril Tablets 2mg° |
3658 |
2mg |
Box of 30 |
Tablet, Scored |
9540 |
9856 |
3.31 |
A |
Omnipharma |
RP Scherer GmbH & Co KG |
Roaccutane 10mg |
1561 |
10mg |
Box of 30 |
Capsule, hard |
59688 |
61661 |
3.31 |
B |
Omnipharma |
RP Scherer GmbH & Co KG |
Roaccutane 20mg |
1562 |
20mg |
Box of 30 |
Capsule, hard |
104711 |
108172 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rocaltrol 0.25µg* |
1565 |
0.25µg |
Box of 30 |
Capsule, hard |
41238 |
42601 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rocaltrol 0.5µg* |
1566 |
0.5µg |
Box of 30 |
Capsule, hard |
78980 |
81591 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rocephin 250mg* |
1567 |
250mg |
1+1x2ml |
Powder and solvent for solution for injection |
13162 |
13597 |
3.3 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rocephin IM 1g |
1571 |
1g |
1+1x3.5ml |
Powder and solvent for solution for injection |
44602 |
46076 |
3.3 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rocephin IM 500mg* |
1568 |
500mg |
1+1x2ml |
Powder and solvent for solution for injection |
24000 |
24793 |
3.3 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rocephin IV 1g |
1570 |
1g |
1+1x10ml |
Powder and solvent for solution for injection |
44602 |
46076 |
3.3 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Rocephin IV 500mg* |
1569 |
500mg |
1+1x5ml |
Powder and solvent for solution for injection |
24000 |
24793 |
3.3 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Roferon-A* |
1572 |
3MIU |
Box of 5 |
Solution for injection |
308098 |
318281 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Roferon-A* |
3477 |
3MIU |
Box of 1 |
Solution for injection |
68624 |
70893 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Romilar Expectorant* |
1573 |
multicompo |
100ml |
Syrup |
7000 |
7231 |
3.3 |
A |
Unknown |
F. Hoffmann La Roche Ltd |
Rovigon* |
1574 |
9mg/70mg |
Box of 30 |
Tablet, Sugar-Coated |
10135 |
10470 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Sandimmun Ampoules 250mg |
845 |
250mg |
10x5ml |
Solution for injection |
314729 |
325131 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
RP Scherer GmbH & Co KG |
Sandimmun Neoral 100mg |
869 |
100mg |
Box of 50 |
Capsule, hard |
482546 |
498495 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
RP Scherer GmbH & Co KG |
Sandimmun Neoral 25mg |
867 |
25mg |
Box of 50 |
Capsule, hard |
138483 |
143060 |
3.31 |
C |
Khalil Fattal & Fils S.A.L. |
RP Scherer GmbH & Co KG |
Sandimmun Neoral 50mg |
868 |
50mg |
Box of 50 |
Capsule, hard |
256564 |
265044 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma SAS, Huningue |
Sandimmun Neoral Oral Solution |
870 |
100mg/ml |
50ml |
Oral solution |
437289 |
451742 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Sandimmun Neoral Oral Solution* |
846 |
100mg/ml |
50ml |
Oral solution |
693734 |
716663 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Sandimmun Soft 100mg* |
855 |
100mg |
Box of 50 |
Capsule, hard |
611147 |
631346 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Sandimmun Soft 25mg* |
853 |
25mg |
Box of 50 |
Capsule, hard |
170723 |
176365 |
3.3 |
C |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Sandimmun Soft 50mg* |
854 |
50mg |
Box of 50 |
Capsule, hard |
325630 |
336393 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Sandostatin 0.05mg° |
849 |
0.05mg |
5x1ml |
Solution for injection |
80350 |
83006 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Sandostatin 0.1mg |
850 |
0.1mg/ml |
5x1ml |
Solution for injection |
109887 |
113520 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Sandoz GmbH |
Sandostatin LAR 20mg |
5848 |
20mg |
1+1x2ml |
Powder for solution for injection |
2889044 |
2984533 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Sandoz GmbH |
Sandostatin LAR 30mg |
5849 |
30mg |
1+1x2ml |
Powder for solution for injection |
4209662 |
4348801 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Sebivo* |
5151 |
600mg |
Box of 28 |
Tablet, Film-Coated |
859091 |
887486 |
3.31 |
D |
Mectapharm S.A.L. |
Mepha Ltd |
Simepar° |
1583 |
multicompo |
Box of 40 |
Capsule |
23996 |
24789 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Sinecod Drops* |
1994 |
5mg/ml |
20ml |
Oral drops, solution |
4925 |
5088 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Sinecod Syrup* |
1993 |
1.5mg/ml |
200ml |
Syrup |
8916 |
9211 |
3.31 |
A |
Omnipharma |
ICN Switzerland AG |
Solcoseryl Ampoules |
1283 |
85mg |
6x2ml |
Solution for injection |
28885 |
29840 |
3.31 |
B |
Omnipharma |
Valeant Pharmaceuticals Switzerland GmbH |
Solcoseryl Jelly° |
1284 |
4.15mg/g |
20g |
Oral Jelly |
7730 |
7985 |
3.3 |
A |
Omnipharma |
Valeant Pharmaceuticals Switzerland GmbH |
Solcoseryl Ointment* |
1286 |
1g |
20g |
Cutaneous ointment |
5081 |
5249 |
3.31 |
A |
Biopharm |
ICN Switzerland AG |
Solcoseryl Ophthalmic Gel* |
1285 |
8.3mg/5mg |
5g |
Eye Gel |
8108 |
8376 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Spasmo-Canulase* |
2005 |
multicompo |
Box of 20 |
Tablet |
10757 |
11112 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Spersacarpine 1%* |
2079 |
1% |
10ml |
Eye drops |
8714 |
9002 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Spersacarpine 2%* |
2072 |
2% |
10ml |
Eye drops |
9472 |
9785 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Spersacarpine 4%* |
2078 |
4% |
10ml |
Eye drops |
9472 |
9785 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Spersacet C* |
2073 |
0.5%/0.1% |
10ml |
Eye drops |
6820 |
7045 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Excelvision AG |
Spersadex Comp* |
2055 |
0.5%/0.1% |
5ml |
Eye drops |
5304 |
5480 |
3.32 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Spersadex* |
2074 |
0.1% |
5ml |
Eye drops, suspension |
7376 |
7619 |
3.29 |
A |
Khalil Fattal & Fils S.A.L. |
Excelvision AG |
Spersallerg* |
2056 |
0.5mg/0.4mg/ml |
10ml |
Eye drops |
3536 |
3653 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Spersanicol* |
2057 |
0.5% |
10ml |
Eye drops |
6820 |
7045 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Spersapolymyxin* |
2050 |
3.5mg/15000IU/ml |
5ml |
Eye drops, solution |
7325 |
7567 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Orion Corporation |
Stalevo 100/25/200mg |
4009 |
200/100/25mg |
Box of 100 |
Tablet, Film-Coated |
244412 |
252490 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Orion Corporation |
Stalevo 125/31.25/200mg* |
6184 |
31.25/200/125mg |
Box of 100 |
Tablet, Film-Coated |
238255 |
246130 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Orion Corporation |
Stalevo 150/37.5/200mg |
4010 |
37.5/200/150mg |
Box of 100 |
Tablet, Film-Coated |
256965 |
265458 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Orion Corporation |
Stalevo 200/50/200mg |
5668 |
200/50/200mg |
Box of 30 |
Tablet, Film-Coated |
102728 |
106124 |
3.31 |
B |
Khalil Fattal & Fils S.A.L. |
Orion Corporation |
Stalevo 50/12.5/200mg* |
4011 |
50/12.5/200mg |
Box of 100 |
Tablet, Film-Coated |
235020 |
242788 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Orion Corporation |
Stalevo 75/18.75/200mg* |
6183 |
18.75/200/75mg |
Box of 100 |
Tablet, Film-Coated |
233673 |
241396 |
3.31 |
D |
Multimarketing S.A.R.L. |
Lagap SA |
Suissmycetin Capsules* |
1696 |
|
Box of 12 |
Capsule |
5607 |
5793 |
3.32 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Suissmycetin Suspension* |
1697 |
|
60ml |
Oral suspension |
5203 |
5375 |
3.31 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
F. Hoffmann La Roche Ltd |
Supradyn SC Tablets* |
1592 |
multicompo |
Box of 30 |
Tablet, Sugar-Coated |
12189 |
12592 |
3.31 |
A |
Mersaco |
Grunenthal Pharma AG |
Synalar Cream* |
1953 |
0.025% |
15g |
Cutaneous Cream |
5330 |
5506 |
3.3 |
A |
Mersaco |
Grunenthal Pharma AG |
Synalar N* |
1956 |
0.025%/0.35% |
15g |
Cutaneous ointment |
5633 |
5819 |
3.3 |
A |
Mersaco |
Grunenthal Pharma AG |
Synalar N* |
1955 |
0.025%/0.35% |
15g |
Cutaneous Cream |
5633 |
5819 |
3.3 |
A |
Mersaco |
Grunenthal Pharma AG |
Synalar Ointment* |
1954 |
0.025% |
15g |
Cutaneous ointment |
5330 |
5506 |
3.3 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Tamiflu Capsules |
1602 |
75mg |
Box of 10 |
Capsule, hard |
79269 |
81889 |
3.31 |
B |
Omnipharma |
Rottendorf Pharma GmbH |
Tamiflu Suspension* |
3918 |
12mg/ml |
75ml |
Powder for oral suspension |
49780 |
51425 |
3.3 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Tarceva 100mg |
5562 |
100mg |
Box of 30 |
Tablet, Film-Coated |
6129165 |
6331744 |
3.31 |
D |
Omnipharma |
Kremers Urban Pharmaceuticals Inc |
Tarceva 100mg* |
3947 |
100mg |
Box of 30 |
Tablet, Film-Coated |
6129165 |
6331744 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Tarceva 150mg |
5561 |
150mg |
Box of 30 |
Tablet, Film-Coated |
7439945 |
7685847 |
3.31 |
D |
Omnipharma |
Kremers Urban Pharmaceuticals Inc |
Tarceva 150mg* |
3948 |
150mg |
Box of 30 |
Tablet, Film-Coated |
7439945 |
7685847 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Tasigna 150mg |
6207 |
150mg |
Box of 112 |
Capsule, hard |
7974589 |
8238168 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Tasigna 150mg* |
6208 |
150mg |
Box of 28 |
Capsule, hard |
2093319 |
2162508 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Tasigna 200mg |
5120 |
200mg |
Box of 112 |
Capsule, hard |
9920900 |
10248810 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Tasigna 200mg* |
5118 |
200mg |
Box of 28 |
Capsule, hard |
2610767 |
2697059 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Tasmar* |
1603 |
100mg |
Box of 30 |
Tablet, Film-Coated |
110651 |
114308 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Tavegyl Ampoules* |
841 |
2mg |
5x2ml |
Solution for injection |
9189 |
9493 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Tavegyl Tablets* |
842 |
1mg |
Box of 20 |
Tablet |
8784 |
9074 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Tetrasuiss Capsules* |
1700 |
250mg |
Box of 16 |
Capsule, hard |
9219 |
9524 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Tetrasuiss Suspension* |
1701 |
250mg/5ml |
60ml |
Oral suspension |
3359 |
3470 |
3.3 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Tilcotil Ampoules* |
3402 |
20mg |
5x2ml |
Powder for solution for injection |
19459 |
20103 |
3.31 |
A |
Omnipharma |
F. Hoffmann La Roche Ltd |
Tilcotil Suppositories* |
1612 |
20mg |
Box of 10 |
Suppository |
31539 |
32582 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Tilcotil Tablets* |
6579 |
20mg |
Box of 10 |
Tablet, Film-Coated |
10649 |
11001 |
3.31 |
A |
Mersaco |
Cilag AG |
Topamax 100mg* |
1944 |
100mg |
Box of 60 |
Tablet |
223989 |
231393 |
3.31 |
C |
Mersaco |
Cilag AG |
Topamax 200mg* |
1945 |
200mg |
Box of 60 |
Tablet |
389340 |
402209 |
3.31 |
D |
Mersaco |
Cilag AG |
Topamax 25mg* |
1909 |
25mg |
Box of 60 |
Tablet |
66383 |
68577 |
3.31 |
B |
Mersaco |
Cilag AG |
Topamax 50mg* |
1943 |
50mg |
Box of 60 |
Tablet |
124473 |
128587 |
3.31 |
C |
Mersaco |
Grunenthal Pharma AG |
Topsym Polyvalent Cream* |
1948 |
0.5mg/0.25mg/3.5mg/100.000IU/g |
15g |
Cutaneous Cream |
13236 |
13673 |
3.3 |
A |
Mersaco |
Grunenthal Pharma AG |
Topsym Polyvalent Ointment* |
1960 |
0.5mg/0.25mg/2.5mg/100.000IU/g |
15g |
Cutaneous ointment |
8411 |
8689 |
3.31 |
A |
Mersaco |
Grunenthal Pharma AG |
Topsym* |
1959 |
0.05% |
15g |
Cutaneous ointment |
8108 |
8376 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Trabit Ampoules* |
1614 |
multicompo |
3x2ml + 3x1ml |
Solution for injection |
26158 |
27022 |
3.3 |
B |
Mectapharm S.A.L. |
Mepha Ltd |
Trabit Tablets* |
1615 |
multicompo |
Box of 20 |
Tablet |
14650 |
15134 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Triaminic Bitab* |
874 |
|
Box of 12 |
Tablet |
5649 |
5835 |
3.29 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Triaminic Drops* |
875 |
|
10ml |
Oral drops, solution |
5649 |
5835 |
3.29 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Triatussic* |
877 |
2mg/10mg/12.5mg/5ml |
100ml |
Oral suspension |
10162 |
10498 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Triatussic* |
876 |
2mg/10mg/12.5mg |
Box of 24 |
Tablet |
7297 |
7538 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Triherpine* |
2060 |
10mg |
2.5g |
Eye ointment |
17176 |
17744 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Trilagavit Ampoules* |
1705 |
multicompo |
3x3ml |
Solution for injection |
6163 |
6367 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Trilagavit Tablets |
5712 |
200mg/100mg/1mg |
Box of 30 |
Tablet, Film-Coated |
12377 |
12786 |
3.3 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Trilagavit Tablets* |
1704 |
200mg/100mg/1mg |
Box of 15 |
Tablet |
6214 |
6419 |
3.3 |
A |
UPO S.A.L. |
Vifor International |
Triofan Gouttes Nasales Adults° |
1120 |
10mg/1mg/ml |
10ml |
Nasal drops, solution |
8784 |
9074 |
3.3 |
A |
UPO S.A.L. |
Vifor International |
Triofan Gouttes Nasales Children° |
1119 |
5mg/0.5mg |
10ml |
Nasal drops, solution |
7892 |
8153 |
3.31 |
A |
UPO S.A.L. |
Vifor SA |
Triofan Nasal Spray Adults and Children° |
3688 |
10mg/1mg/ml |
10ml |
Nasal spray, solution |
11054 |
11419 |
3.3 |
A |
UPO S.A.L. |
Vifor SA |
Triofan Nasal Spray Small Children and Babies° |
3687 |
5mg/0.5mg/ml |
10ml |
Nasal spray, solution |
10405 |
10749 |
3.31 |
A |
Multimarketing S.A.R.L. |
Lagap SA |
Trypcyclin* |
1706 |
|
Box of 12 |
Capsule |
12933 |
13360 |
3.3 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
DMS Farmaceutici spA |
Tuscalman A |
3774 |
5mg/25mg |
Box of 10 |
Suppository |
6971 |
7202 |
3.31 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
DMS Farmaceutici spA |
Tuscalman B |
3775 |
10mg/50mg |
Box of 10 |
Suppository |
6971 |
7202 |
3.31 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
DMS Farmaceutici spA |
Tuscalman Sirop* |
3429 |
100mg/15mg/10ml |
120ml |
Syrup |
7027 |
7259 |
3.3 |
A |
Droguerie Columbus |
Cilag AG |
Tylenol Forte |
1930 |
500mg |
Box of 20 |
Caplet |
3054 |
3155 |
3.31 |
A |
Droguerie Columbus |
Lusomedicamenta Sociedade Tecnica Farmaceutica SA |
Tylenol Suppositories 100mg |
6394 |
100mg |
Box of 10 |
Suppository |
4595 |
4746 |
3.29 |
A |
Droguerie Columbus |
Lusomedicamenta Sociedade Tecnica Farmaceutica SA |
Tylenol Suppositories 200mg |
6395 |
200mg |
Box of 10 |
Suppository |
5189 |
5361 |
3.31 |
A |
Droguerie Columbus |
Lusomedicamenta Sociedade Tecnica Farmaceutica SA |
Tylenol Suppositoriesl 350mg |
6396 |
350mg |
Box of 10 |
Suppository |
5865 |
6059 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Ultracortenol Eye Drops* |
2063 |
5mg/ml |
5ml |
Eye drops |
6567 |
6784 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Ultracortenol Eye Ointment* |
2062 |
5mg/g |
5g |
Eye ointment |
6795 |
7019 |
3.3 |
A |
UPO S.A.L. |
OM Pharma |
Uro-Vaxom |
1271 |
6mg |
Box of 30 |
Capsule, hard |
61277 |
63302 |
3.3 |
B |
UPO S.A.L. |
OM Pharma |
Uro-Vaxom* |
1272 |
6mg |
Box of 90 |
Capsule, hard |
150429 |
155401 |
3.31 |
C |
Multimarketing S.A.R.L. |
Lagap SA |
Urocin* |
1707 |
|
Box of 16 |
Capsule |
15155 |
15656 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Llc |
Uvamin-Retard° |
1627 |
100mg |
Box of 20 |
Capsule |
8841 |
9133 |
3.3 |
A |
New Allpharma |
Medinova Ltd |
Vagomycin* |
3849 |
10mg/15mg/42.5mg |
Box of 10 |
Tablet, Vaginal |
8919 |
9214 |
3.31 |
A |
Omnipharma |
Patheon Inc |
Valcyte* |
5053 |
450mg |
Box of 60 |
Tablet, Film-Coated |
4542307 |
4692438 |
3.31 |
D |
Omnipharma |
Cenexi SAS |
Valium Ampoules* |
1628 |
10mg |
10x2ml |
Solution for injection |
7405 |
7650 |
3.31 |
A |
Omnipharma |
Roche Farma SA |
Valium Tablets° |
1629 |
5mg |
Box of 25 |
Tablet |
8351 |
8627 |
3.3 |
A |
UPO S.A.L. |
Vifor International |
Venofer IV* |
1121 |
100mg |
5x5ml |
Solution for injection |
65632 |
67802 |
3.31 |
B |
Mersaco |
Novartis Consumer Health SA |
Venoruton Capsules* |
1987 |
300mg |
Box of 20 |
Capsule, hard |
5405 |
5584 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Venoruton Forte* |
1995 |
500mg |
Box of 30 |
Tablet |
21470 |
22180 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Venoruton Gel* |
5130 |
2% |
40g |
Cutaneous Gel |
5380 |
5558 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Vibrocil Nasal Drops° |
1988 |
0.25mg/2.5mg/ml |
15ml |
Nasal drops, solution |
4269 |
4410 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Vibrocil Nasal Gel° |
1989 |
0.25mg/2.5mg/g |
12g |
Nasal Gel |
4749 |
4906 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Vibrocil Nasal Spray* |
1978 |
0.25mg/2.5mg/ml |
15ml |
Nasal spray, solution |
5658 |
5845 |
3.31 |
A |
Mersaco |
Novartis Consumer Health SA |
Vibrocil Spray Nasal** |
1990 |
0.25mg/2.5mg/ml |
10ml |
Nasal spray, solution |
5810 |
6002 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Viscotears* |
2053 |
2mg/g |
10g |
Eye Gel |
7072 |
7306 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharmaceuticals UK Ltd, Horsham |
Viskaldix* |
844 |
5mg/10mg |
Box of 30 |
Tablet, Scored |
17567 |
18148 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Farma SpA, Torre Annunziata |
Visken° |
843 |
5mg |
Box of 30 |
Tablet |
8108 |
8376 |
3.31 |
A |
Pharmacie Traboulsi |
Geistlich Pharma AG |
Vita-Ferin-C* |
1804 |
multicompo |
Box of 30 |
Capsule |
20811 |
21499 |
3.31 |
A |
Pharmacie Traboulsi |
Geistlich Pharma AG |
Vita-Gerin* |
1803 |
multicompo |
Box of 30 |
Capsule |
26782 |
27667 |
3.3 |
B |
Pharmaceutica S.A.R.L. |
Dr Grossmann |
Vitarmin* |
1280 |
1g |
Box of 10 |
Tablet, Effervescent |
6892 |
7120 |
3.31 |
A |
Mectapharm S.A.L. |
RP Scherer GmbH & Co KG |
Vitiron° |
1632 |
multicompo |
Box of 30 |
Suscaps |
14296 |
14769 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Vitreolent* |
2064 |
3mg/3mg |
10ml |
Eye drops |
6820 |
7045 |
3.3 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
Institut Serotherapique & Vaccinal Suisse Berne |
Vivotif Berna* |
3430 |
10⁹ germes |
Box of 3 |
Gastro-resistant capsule, hard |
20460 |
21136 |
3.3 |
A |
Droguerie R. Pharaon & Fils S.A.L. |
Institut Serotherapique & Vaccinal Suisse Berne |
Vivotif Berna* |
3776 |
10⁹ germes |
Box of 3 |
Powder for oral suspension |
30413 |
31418 |
3.3 |
B |
Khalil Fattal & Fils S.A.L. |
Novartis Ophthalmics AG |
Voltamicin* |
2075 |
1.0mg/3mg |
5ml |
Eye drops |
18944 |
19570 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Excelvision AG |
Voltaren Ophtha° |
2076 |
0.1% |
5ml |
Eye drops, solution |
12402 |
12812 |
3.31 |
A |
Omnipharma |
Productos Roche SA de CV |
Xeloda 500mg° |
6393 |
500mg |
Box of 120 |
Tablet, Film-Coated |
754896 |
779847 |
3.31 |
D |
Omnipharma |
F. Hoffmann La Roche Ltd |
Xenical* |
1634 |
120mg |
Box of 42 |
Capsule, hard |
71200 |
73554 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Xenical* |
1635 |
120mg |
Box of 84 |
Capsule, hard |
127696 |
131916 |
3.3 |
C |
Omnipharma |
Roche SpA Italy under licence from F. Hoffmann La Roche Ltd Switzerland |
Xenical° |
3057 |
120mg |
Box of 84 |
Capsule, hard |
127696 |
131916 |
3.3 |
C |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma Stein AG |
Xolair Vial 150mg |
5194 |
150mg |
1+1x2ml |
Powder and solvent for solution for injection |
1260001 |
1301647 |
3.31 |
D |
Abela Frères S.A.L. |
UCB Farchim SA |
Xyzal Tablets* |
3554 |
5mg |
Box of 30 |
Tablet, Film-Coated |
32564 |
33641 |
3.31 |
B |
Abela Frères S.A.L. |
UCB Farchim SA |
Xyzal Tablets* |
3553 |
5mg |
Box of 10 |
Tablet, Film-Coated |
11595 |
11978 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma SAS |
Zaditen Pediatric |
878 |
1mg/5ml |
100ml |
Oral solution |
8513 |
8795 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharmaceuticals UK Ltd, Horsham |
Zaditen Tablets* |
879 |
1mg |
Box of 30 |
Tablet |
15946 |
16473 |
3.3 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Zelmac* |
820 |
6mg |
Box of 30 |
Tablet |
74328 |
76785 |
3.31 |
B |
Omnipharma |
F. Hoffmann La Roche Ltd |
Zenapax* |
1637 |
25mg |
1x5ml |
Solution for infusion |
1115213 |
1152073 |
3.31 |
D |
Mectapharm S.A.L. |
Mepha Ltd |
Zenusin 10mg* |
1638 |
10mg |
Box of 50 |
Solucaps |
26658 |
27540 |
3.31 |
B |
Mectapharm S.A.L. |
Mepha Ltd |
Zenusin 20mg* |
1639 |
20mg |
Box of 30 |
Dapocaps |
24627 |
25441 |
3.31 |
A |
Mectapharm S.A.L. |
Mepha Ltd |
Zenusin 5mg* |
1640 |
5mg |
Box of 30 |
Solucaps |
10735 |
11090 |
3.31 |
A |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Zometa |
3999 |
4mg |
1x5ml |
Concentrate for solution for infusion |
727288 |
751326 |
3.31 |
D |
Khalil Fattal & Fils S.A.L. |
Novartis Pharma AG |
Zometa° |
814 |
4mg |
1+1x5ml |
Powder and solvent for solution for injection |
904969 |
934880 |
3.31 |
D |
Mersaco |
Novartis Consumer Health SA |
Zymafluor 0.25mg* |
1991 |
0.25mg |
Box of 400 |
Tablet |
6820 |
7045 |
3.3 |
A |
Mersaco |
Novartis Consumer Health SA |
Zymafluor 1mg* |
1992 |
1mg |
Box of 250 |
Tablet |
10962 |
11325 |
3.31 |
A |